1-alpha-hydroxycholecalciferol for renal osteodystrophy.

Fourteen patients with renal osteodystrophy were treated for at least one year with 1-alpha-hydroxycholecalciferol (1-alpha-OHD3) in a dose varying from 1 microgram/week to 3 microgram/day. Plasma calcium and inorganic phosphorus concentrations increased significantly. The plasma alkaline phosphatas...

Full description

Saved in:
Bibliographic Details
Main Authors: Brownjohn, A M, Goodwin, F J, Hately, W, Marsh, F P, O'Riordan, J L, Papapoulos, S E
Format: Artigo
Language:Inglês
Published: 1977
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1632095/
https://ncbi.nlm.nih.gov/pubmed/912269
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items